Dirk Hubmacher | Mount Sinai

Biography

Research Topics

Biochemistry, Biomedical Sciences, Cell Biology, Developmental Biology, Extracellular Matrix, Growth Factors and Receptors, Integrins, Knockout Mice, Muscle Cells, Orthopaedics, Protein Complexes, Protein Structure/Function, Protein Trafficking & Sorting, Skeletal Biology, Tendon Biology

Publications

36

Publications

Selected Publications

The matrix in focus: new directions in extracellular matrix research from the 2021 ASMB hybrid meeting. Bryan A. Nerger, Tia M. Jones, Keron W.J. Rose, Anna Barqué, Justin S. Weinbaum, Ryan J. Petrie, Joan Chang, Davy Vanhoutte, Kendra LaDuca, Dirk Hubmacher, Alexandra Naba. Biology Open

The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts. Karoline B. Rypdal, Pugazendhi M. Erusappan, A. Olav Melleby, Deborah E. Seifert, Sheryl Palmero, Mari E. Strand, Theis Tønnessen, Christen P. Dahl, Vibeke Almaas, Dirk Hubmacher, Suneel S. Apte, Geir Christensen, Ida G. Lunde. Scientific Reports

Acromelic dysplasias: how rare musculoskeletal disorders reveal biological functions of extracellular matrix proteins. Sarah Stanley, Zerina Balic, Dirk Hubmacher. Annals of the New York Academy of Sciences

View All Publications

Office Locations

Annenberg Building Floor 20 Room 80B

1468 Madison Ave

New York, NY 10029

212-241-1625

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Hubmacher during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Forty51 Ventures
Ines Mandl Research Foundation

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Hubmacher during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Forty51 Ventures
Ines Mandl Research Foundation

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.